Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianjiang Liu

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Gene|December 10, 2013
The Cytochrome P4501A1 gene polymorphisms and idiopathic male infertility risk: a meta-analysisJianzheng Fang, Shangqian Wang, Hainan Wang, et al.
International Journal of Oncology|April 11, 2017
High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinomaJingyuan Tang, Zhiqiang Qin, Peng Han, et al.
Cell Death & Disease|November 18, 2025
Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Cell Death & Disease|August 5, 2025
SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2015
Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cellsJianzheng Fang, Hainan Wang, Wei Xi, et al.
Cell Death & Disease|February 17, 2018
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathwaysChao Liang, Shangqian Wang, Chao Qin, et al.
Oncology Letters|May 29, 2018
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9Yibo Hua, Chao Liang, Chenkui Miao, et al.
World Journal of Surgical Oncology|April 30, 2014
Modified liver mobilization for the treatment of renal cell carcinoma with thrombosis involving the intrahepatic inferior vena cavaZhijian Han, Changjun Yin, Xiaoxin Meng, et al.
Cell Death & Disease|May 5, 2026
Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Biomed Research International|December 30, 2017
Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-AnalysisChenkui Miao, Kai Zhao, Jundong Zhu, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Gene|December 10, 2013
The Cytochrome P4501A1 gene polymorphisms and idiopathic male infertility risk: a meta-analysisJianzheng Fang, Shangqian Wang, Hainan Wang, et al.
International Journal of Oncology|April 11, 2017
High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinomaJingyuan Tang, Zhiqiang Qin, Peng Han, et al.
Cell Death & Disease|November 18, 2025
Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Cell Death & Disease|August 5, 2025
SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 12, 2015
Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cellsJianzheng Fang, Hainan Wang, Wei Xi, et al.
Cell Death & Disease|February 17, 2018
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathwaysChao Liang, Shangqian Wang, Chao Qin, et al.
Oncology Letters|May 29, 2018
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9Yibo Hua, Chao Liang, Chenkui Miao, et al.
World Journal of Surgical Oncology|April 30, 2014
Modified liver mobilization for the treatment of renal cell carcinoma with thrombosis involving the intrahepatic inferior vena cavaZhijian Han, Changjun Yin, Xiaoxin Meng, et al.
Cell Death & Disease|May 5, 2026
Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancerMin Tang, Luotong Xue, Bao Wang, et al.
Biomed Research International|December 30, 2017
Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-AnalysisChenkui Miao, Kai Zhao, Jundong Zhu, et al.
Pageof 8